Lung Cancer Models

Lung cancer remains one of the leading causes of cancer-related mortality worldwide. Early detection and effective treatment strategies are vital in improving patient outcomes. Recent advances in computational modeling have provided valuable insights into the pathophysiology of lung cancer, offering new avenues for diagnosis, treatment, and prognosis. Lung cancer models, ranging from in vitro and in vivo experimental systems to computational simulations, are instrumental in understanding tumor growth, metastasis, and response to therapies. These models encompass a variety of approaches, including genetic and molecular models, patient-derived xenografts (PDXs), and advanced in silico models that simulate tumor progression and treatment responses. Additionally, the integration of artificial intelligence and machine learning techniques has enhanced the predictive power of these models, enabling personalized treatment regimens based on patient-specific data. Despite significant progress, challenges remain in replicating the complexity of human lung cancer, emphasizing the need for continued innovation in modeling techniques. This abstract provides a comprehensive overview of the current state of lung cancer models and their role in advancing the understanding and treatment of this devastating disease.